Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients

Blood Stem Cell Transplant Failure Clinical Trial

Official title:
Cytokine Assay for Early Identification of Pediatric Stem Cell Transplant Recipients at Risk for Respiratory Failure

Status Terminated

Clinical Trial Summary

The aim of our study is to determine whether a clinically relevant laboratory measurement (of seven specific immunologic biochemicals in the blood) can identify which bone marrow transplant recipients are likely to progress to respiratory failure. Our ultimate goal is to devise a comprehensive and inclusive laboratory test that is effective at determining who is likely to go on to respiratory failure, in order to facilitate early medical intervention.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Blood Stem Cell Transplant Failure

Clinical Trial Details

NCT number	NCT01135355
Study type	Observational
Source	Stanford University
Contact
Status	Terminated
Phase
Start date	July 2008
Completion date	January 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05705622` - The Effect of Nursing Education on Oral Mucositis in Bone Marrow Transplant Patients	N/A
Completed	`NCT01010217` - Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide	Phase 2
Withdrawn	`NCT01569373` - Analysis of Biomarkers for Acute Graft-versus-Host Disease (GVHD)
Completed	`NCT02997813` - Assessment of Mobilization Cost for Multiple Myeloma Using 2 Different Mobilization Strategies	N/A
Completed	`NCT01174277` - Pilot Study: Patients With Chronic Active Graft Versus Host Disease That Have Failed or Not Tolerated Standard Therapy.	Phase 0
Active, not recruiting	`NCT04473911` - Haplo Peripheral Blood Sct In GVHD Prevention	Phase 1
Terminated	`NCT00667784` - Long Term Minor Sibling Donor Well-Being	N/A